Recommended Alerts

Sign Up For Alerts

Developments in Drug Pricing and Price Reporting as the Congressional Recess Approaches (August 2021)

As the August congressional recess approaches, there have been several developments in the drug pricing/price reporting space. All branches of government have worked to tackle drug pricing in recent months, and by late August we may have a much stronger sense of the direction the Biden Administration intends to take to address drug pricing through administrative action.

Read More

CMS Aims to Clarify Medicare Policy on Clinical Trial Coverage

Time to Read: 1 minutes Practices: Health Care, Life Sciences

Printer-Friendly Version

The Centers for Medicare & Medicaid Services has recently launched a number of initiatives addressing Medicare coverage of clinical trial services, including an upcoming "Question & Answer" document on coverage of clinical trial services; proposed revisions to the national coverage decision on clinical trial services; and a revised guidance document for certain national coverage decisions. To learn more about these significant CMS initiatives, click "Download PDF."

Printer-Friendly Version

Cookie Settings